Waters ROE 2010-2024 | WAT
Current and historical return on equity (ROE) values for Waters (WAT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Waters ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $0.64B | $1.83B | 41.83% |
| 2024-09-30 | $0.62B | $1.60B | 45.96% |
| 2024-06-30 | $0.60B | $1.41B | 50.46% |
| 2024-03-31 | $0.60B | $1.26B | 59.16% |
| 2023-12-31 | $0.64B | $1.15B | 75.05% |
| 2023-09-30 | $0.65B | $0.91B | 94.07% |
| 2023-06-30 | $0.68B | $0.77B | 119.47% |
| 2023-03-31 | $0.69B | $0.60B | 146.52% |
| 2022-12-31 | $0.71B | $0.50B | 171.01% |
| 2022-09-30 | $0.70B | $0.39B | 183.42% |
| 2022-06-30 | $0.70B | $0.39B | 196.36% |
| 2022-03-31 | $0.70B | $0.38B | 215.62% |
| 2021-12-31 | $0.69B | $0.37B | 238.21% |
| 2021-09-30 | $0.69B | $0.30B | 270.57% |
| 2021-06-30 | $0.66B | $0.27B | 383.16% |
| 2021-03-31 | $0.62B | $0.23B | 1075.98% |
| 2020-12-31 | $0.52B | $0.23B | -614.12% |
| 2020-09-30 | $0.51B | $-0.04B | -256.35% |
| 2020-06-30 | $0.52B | $-0.19B | -327.62% |
| 2020-03-31 | $0.54B | $-0.34B | 1820.34% |
| 2019-12-31 | $0.59B | $-0.22B | 166.29% |
| 2019-09-30 | $0.58B | $0.12B | 71.84% |
| 2019-06-30 | $0.58B | $0.56B | 46.63% |
| 2019-03-31 | $0.59B | $0.97B | 37.02% |
| 2018-12-31 | $0.59B | $1.57B | 31.54% |
| 2018-09-30 | $0.06B | $1.88B | 2.73% |
| 2018-06-30 | $0.05B | $1.98B | 2.28% |
| 2018-03-31 | $0.03B | $2.12B | 1.14% |
| 2017-12-31 | $0.02B | $2.23B | 0.86% |
| 2017-09-30 | $0.55B | $2.63B | 22.27% |
| 2017-06-30 | $0.54B | $2.52B | 22.67% |
| 2017-03-31 | $0.53B | $2.40B | 23.42% |
| 2016-12-31 | $0.52B | $2.30B | 23.65% |
| 2016-09-30 | $0.50B | $2.26B | 23.25% |
| 2016-06-30 | $0.49B | $2.15B | 23.63% |
| 2016-03-31 | $0.47B | $2.10B | 23.17% |
| 2015-12-31 | $0.47B | $2.06B | 23.98% |
| 2015-09-30 | $0.47B | $1.97B | 24.49% |
| 2015-06-30 | $0.47B | $1.93B | 24.75% |
| 2015-03-31 | $0.46B | $1.86B | 24.56% |
| 2014-12-31 | $0.43B | $1.90B | 23.30% |
| 2014-09-30 | $0.42B | $1.84B | 23.23% |
| 2014-06-30 | $0.41B | $1.84B | 23.11% |
| 2014-03-31 | $0.40B | $1.82B | 23.75% |
| 2013-12-31 | $0.45B | $1.76B | 28.22% |
| 2013-09-30 | $0.48B | $1.62B | 31.83% |
| 2013-06-30 | $0.49B | $1.52B | 33.48% |
| 2013-03-31 | $0.49B | $1.48B | 35.69% |
| 2012-12-31 | $0.46B | $1.47B | 34.55% |
| 2012-09-30 | $0.42B | $1.33B | 33.12% |
| 2012-06-30 | $0.43B | $1.26B | 34.43% |
| 2012-03-31 | $0.43B | $1.29B | 34.86% |
| 2011-12-31 | $0.43B | $1.23B | 36.28% |
| 2011-09-30 | $0.42B | $1.16B | 36.66% |
| 2011-06-30 | $0.42B | $1.23B | 38.09% |
| 2011-03-31 | $0.40B | $1.15B | 40.55% |
| 2010-12-31 | $0.38B | $1.07B | 42.34% |
| 2010-09-30 | $0.36B | $0.92B | 42.38% |
| 2010-06-30 | $0.34B | $0.81B | 41.89% |
| 2010-03-31 | $0.33B | $0.81B | 41.08% |
| 2009-12-31 | $0.32B | $0.85B | 42.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.520B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.174B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |